Events | December 06, 2021
Early management of Covid-19 key to reduce mortality and hospitalisation
The Institute of Pulmonology Medical Research & Development organised a symposium on early management of Covid-19
The Institute of Pulmonology Medical Research & Development organised a symposium on early management of Covid-19
Expanded EUA includes both treatment of patients with Covid-19 and post-exposure prophylaxis (PEP) in high-risk pediatric and infant patients
The combination rapid antigen test quickly differentiates between SARS-CoV-2 and influenza viruses A and B infections, with results ready in less than 30 minutes, allowing informed decisions on patient and pandemic management decisions
Fexofinadine is the most widely used, second-generation antihistamine drug for the treatment of allergy symptoms and hay fever
Serum has a capacity of 250-275 million whereas Bharat Biotech has a capacity of 50-60 million
IIRSI 2021 aims to bring together ophthalmologists across India and abroad to discuss the advancement in technology and their experience in IOL implantation and Refractive Surgery
The hospital is scheduled to open in 2024 with a bed capacity of 225
Lupin had earlier received the U.S. FDA acceptance of the Biologics License Application (BLA) for Its proposed biosimilar
MJ will be paid a one-time lumpsum licence fee of Rs 15 crore
The fund aims at investing in companies that extends human healthspan
Subscribe To Our Newsletter & Stay Updated
